ArticleAmerican journal of translational research2021
Application of Guijiaosan Shenque acupoint paste can improve the scores of obesity, endocrine and TCM symptoms in treating obese polycystic ovary syndrome.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Woxuanzhongzhou formula improves DHEAS and high-fat diet-induced IR and anovulatory mice via AMPK/PGC1- α/Irisin pathway.Journal of ovarian research · 2025Article
- Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment.Journal of ovarian research · 2023Review
- Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism.Frontiers in endocrinology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effect of Guijiaosan Shenque acupoint paste on the obesity, endocrine, and TCM symptom scores of obese polycystic ovary syndrome (PCOS) patients with phlegm-dampness block.
methodsFrom January 2020 to December 2020, 80 PCOS patients with phlegm-dampness block were recruited as the study cohort and randomly divided into a research group (RG) or a control group (CG), with 40 cases in each group. The CG was treated with herbal decoctions according to syndrome differentiation, while the RG was administered Guijiaosan paste at the Shenque acupoint in addition to the treatment administered to the CG. The body weight indexes, endocrine function, insulin resistance indexes, TCM syndrome scores, and safety index changes were compared between the two groups before and after the treatment.
resultsCompared with the CG, the body weight indexes, endocrine function, insulin resistance indexes, and TCM syndrome scores in the RG were significantly improved (P<0.05), and there was no significant difference in the safety indexes between the two groups before the treatment (P>0.05).
conclusionThe application of Guijiaosan paste at the Shenque acupoint can effectively improve the obesity and endocrine functions of obese patients with PCOS and improve their clinical symptoms, so it is worthy of clinical promotion.
Indexed as
Identifiers
34650744PMC8506986W3207720716What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.